POSTER LIBRARY

Use the links below to download posters from our international meetings.

FALL SUMMIT 2022

2022 XCN AZ HF resectable NSCLC 

NCODA Rosentreter

Advancing Cannabinoid Education & Science Study

CDK4 6 inhibitors treatment use in women treated for advanced breast cancer Integrating ASCO NCODA patient centered standards in a community pharmacy

CoE MIP Poster 

DeFi- A Phase 3 Trial of Nirogacestat for Progressing Desmoid Tumors (DT)

Impact of patient support program participation on treatment compliance for patients initiating ibrutinib

Lack of Management Education in the Pharmacy School Curriculum

NCCN- ASCO NCODA Standards 

NCODA CAWT 

NCODA GROWTH

NCODA IMW 

NCODA Legislative Initiatives

NCODA Nursing Committee 

NCODA OPTA 

NCODA Positive Quality Interventions (PQI) 

NCODA Poster PSO 

NCODA PQI in Action 

NCODA TSK 

NCODA Utilization of PQIs and TSKs with Selinexor 

Population Pharmacogenomics Analysis Highlights the Significance of Pharmacogenomic Testing in the Community Oncology Setting

Poster Trialing an Evidence based Role for Nursing- Oral Oncolytic Nurse Navigator

Retrospective Analysis of a Pharmacist-Led Dose Rounding Initiative at an Outpatient Oncology Practice

Retrospective Comparison of Patient Outcomes on Pacritinib vs Ruxolitinib

Robotics & Oncology

SDOH Poster

WE PLEDGE – All these voices combine as one, with one goal…a pledge to do the very best we can to get patients better

Biosimilar Adoption- Patient and Provider Considerations

Covid Prevention in Adult Cancer Patients

Factors Associated with Initiation of Oral Antineoplastic Therapies in an Urban Academic Medical Center

Impact of COVID-19 Pandemic on Cancer Care Delivery in Ontario

Informal Caregiver Burnout

Teaching and Reinforcing Pharmaceutical Calculations Through an Interactive Immediate Response Learning Program

OCS 2022

SPRING FORUM 2022

5-FU Induced Hyperammonemic Encephalopathy

7 Clinical Perspective- Ribociclib Overall Survival Benefit and Management Strategies, Including Mobile Technologies

A Pandemic’s Influence on Cancer Screening Rates for Adults in the United States

A successful model of biosimilar adoption in a community oncology practice

A treatment journey to remission: a case report of a cholangiocarcinoma patient treated with surgery, adjuvant and palliative chemotherapy, orthotropic liver transplantation, radiotherapy; a journey from despair to hope

Access to Bedside Hydration and Hydration status among Oncology in-patients- A Quality improvement Project

BURDEN OF CHEMOTHERAPY-INDUCED MYELOSUPPRESSION AMONG PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER- A RETROSPECTIVE STUDY OF DATA FROM COMMUNITY ONCOLOGY PRACTICES

BURDEN OF MYELOSUPPRESSION AMONG PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER TREATED WITH CHEMOTHERAPY IN A COMMUNITY ONCOLOGY SETTING

Cabazitaxel Cost Consequence Poster ESMO2021

Cannabinoids and weight management in oncology

Compliance of Letermovir Prescribing at a London Oncology Referral Hospital

DPYD Testing to Prevent Severe Fluoropyrimidine Chemotherapy Toxicity

Financial Toxicity

Hand Foot Syndrome vs Hand Foot Skin Reaction

Implementation of Guidelines Concordant Treatment Options in Patients with HR (Hormone Receptor Positive) and HER 2 neu Negative Advanced Breast Cancer

Importance of Smoking Cessation in Oncology Care

Improving Care Coordination for Patients on Oral Oncolytic Therapy

Leptomeningeal Involvement in CLL Treated with Ibrutinib

Multi-locus Inherited Neoplasia Alleles Syndrome (MINAS) with Birt-Hogg-Dube Syndrome (BHG) and Li-Fraumeni Syndrome (LFS)- Case

NCCN- ASCO NCODA Standards SF2022

NCODA CAWT SF2022pdf

NCODA CoE MIP SF2022

NCODA GROWTH SF2022

NCODA International Webinar SF2022

NCODA Nursing Committee SF2022

NCODA OPTA SF2022

NCODA Positive Quality Interventions (PQI) SF2022

NCODA PQI in Action SF2022

NCODA PSO SF2022

NCODA Selinexor Project Concept Poster SF2022

NCODA TSK SF2022

Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients With FGFR2 Fusions_Rearrangements

Precision Medicine- A Pinnacle of Innovation or a Pitfall of Explicit and Implicit Biases

Real World Outcomes Among Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Metastatic Non Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors versus Immunotherapy or Chemotherapy in First line Setting

Real World Treatment Patterns of Metastatic Non Small Cell Lung Cancer (mNSCLC) Patients Receiving Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs)

The Role of Precision Medicine in Lung Cancer- Case Study and Review of Literature

Treatment Utilization and Characteristics Among Patients With Higher-Risk Myelodysplastic Syndromes According to Hypomethylating Agent Use

Use of Gold Nanoparticles in Photodynamic Therapy for the Treatment of Cancer

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization

error: